Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis by Thwaites, Guy et al.
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2008, p. 1363–1368 Vol. 46, No. 4
0095-1137/08/$08.000 doi:10.1128/JCM.02180-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Relationship between Mycobacterium tuberculosis Genotype and the
Clinical Phenotype of Pulmonary and Meningeal Tuberculosis 
Guy Thwaites,1,2* Maxine Caws,2,3 Tran Thi Hong Chau,2,4 Anthony D’Sa,5 Nguyen Thi Ngoc Lan,6
Mai Nguyet Thu Huyen,6 Sebastien Gagneux,7† Phan Thi Hoang Anh,6 Dau Quang Tho,2
Estee Torok,2,3 Nguyen Thi Quynh Nhu,2 Nguyen Thi Hong Duyen,2 Phan Minh Duy,2
Jonathan Richenberg,5 Cameron Simmons,2,3 Tran Tinh Hien,4 and Jeremy Farrar2,3
Centre for Molecular Microbiology and Infection, Imperial College, London, United Kingdom1; Oxford University Clinical Research Unit,
Hospital for Tropical Diseases, 190 Ben Ham Tu, District 5, Ho Chi Minh City, Vietnam2; Centre for Clinical Vaccinology and
Tropical Medicine, Churchill Hospital, Old Road, Headington, Oxford, United Kingdom3; The Hospital for Tropical Diseases,
Ho Chi Minh City, Vietnam4; Department of Radiology, Brighton, and Sussex University Hospitals, Eastern Road,
Brighton, United Kingdom5; Pham Ngoc Thach Hospital for Tuberculosis and Lung Diseases,
Huong Vuong, District 5, Ho Chi Minh City, Vietnam6; and Institute for
Systems Biology, 1441 N. 34th Street, Seattle, Washington7
Received 11 November 2007/Returned for modification 23 December 2007/Accepted 4 February 2008
We used large sequence polymorphisms to determine the genotypes of 397 isolates of Mycobacterium
tuberculosis from human immunodeficiency virus-uninfected Vietnamese adults with pulmonary (n  235) or
meningeal (n  162) tuberculosis. We compared the pretreatment radiographic appearances of pulmonary
tuberculosis and the presentation, response to treatment, and outcome of tuberculous meningitis between the
genotypes. Multivariate analysis identified variables independently associated with genotype and outcome. A
higher proportion of adults with pulmonary tuberculosis caused by the Euro-American genotype had consol-
idation on chest X-ray than was the case with disease caused by other genotypes (P  0.006). Multivariate
analysis revealed that meningitis caused by the East Asian/Beijing genotype was independently associated with
a shorter duration of illness before presentation and fewer cerebrospinal fluid (CSF) leukocytes. Older age,
fewer CSF leukocytes, and the presence of hemiplegia (but not strain lineage) were independently associated
with death or severe disability, although the East Asian/Beijing genotype was strongly associated with drug-
resistant tuberculosis. The genotype of M. tuberculosis influenced the presenting features of pulmonary and
meningeal tuberculosis. The association between the East Asian/Beijing lineage and disease progression and
CSF leukocyte count suggests the lineage may alter the presentation of meningitis by influencing the intrace-
rebral inflammatory response. In addition, increased drug resistance among bacteria of the East Asian/Beijing
lineage might influence the response to treatment. This study suggests the genetic diversity of M. tuberculosis
has important clinical consequences.
There is growing evidence that the genetic diversity of My-
cobacterium tuberculosis may have important clinical conse-
quences (11). Nearly 50 years ago, Mitchison and others com-
pared the consequences of infecting guinea pigs with isolates of
M. tuberculosis from either British or Indian patients with pul-
monary tuberculosis (19, 20). They reported that the British
isolates were more virulent: they caused more-severe and
more-widespread disease and killed a higher proportion of
animals (3). However, the investigators were not able to char-
acterize the genetic diversity of the infecting isolates, and they
could not find any association between virulence in guinea pigs
and the severity and outcome of disease in humans (24).
A further understanding of the relationship between myco-
bacterial genotype and clinical phenotype came with the ad-
vent of mycobacterial genotyping (1, 2). Tuberculosis out-
breaks in the United States and United Kingdom provided
epidemiological evidence that some genotypes of M. tubercu-
losis may be more transmissible and more capable of causing
disease than others (22, 35). Many of these strains have now
been extensively studied and shown to induce different pat-
terns of host immune response and disease in cellular or ani-
mal infection models (8, 22). For example, the W-Beijing ge-
notype—responsible for a large outbreak of drug-resistant
tuberculosis in New York in the 1990s—was shown to dissem-
inate more rapidly and caused more-severe disease than other
strains (17, 33). These unusual characteristics have been partly
explained by the ability of Beijing strains to produce a unique
phenolic glycolipid that attenuates the host’s innate immune
response and ability to control the infection (25). Yet despite
an increased appreciation of the genetic diversity of M. tuber-
culosis and the possible mechanisms underlying differences in
virulence, the degree to which this variation influences disease
severity and outcome in humans is still poorly understood.
Epidemiological studies have found some genotypes of M.
tuberculosis may be associated with tuberculosis affecting dif-
ferent organs. For example, extrapulmonary disease has been
associated with polymorphisms in the mycobacterial plcD gene
(37) and the Beijing family of strains (14), but these associa-
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tions appear to hold for some patient populations but not
others. Investigators in South Africa failed to find any signifi-
cant relationship between mycobacterial genotype and ex-
trapulmonary tuberculosis (23).
A small number of studies have examined whether the my-
cobacterial genotype influences disease presentation and out-
come, often with conflicting results. An association between
pretreatment chest X-ray appearances has been reported by
some (9) but not others (4). van Crevel et al. observed that
Indonesian patients with pulmonary tuberculosis caused by Bei-
jing strains had higher fevers than those infected with other
strains (36), whereas the opposite was reported by Drobniewski et
al. in Russia (9). Maree et al. failed to find a relationship between
mycobacterial genotype and clinical presentation and outcome
for 59 South African children with tuberculous meningitis (18).
Few studies have combined a detailed characterization of
the bacterial genotype with presenting clinical features, disease
severity, and response to treatment for a large number of
patients. The purpose of this study was to examine the influ-
ence of the mycobacterial genotype on the clinical presenta-
tion, disease severity, and outcome in a large group of human
immunodeficiency virus (HIV)-uninfected adults with tubercu-
lous meningitis. We also examined the influence of the myco-
bacterial genotype on pretreatment chest X-ray appearances in
a similarly sized group of HIV-uninfected adults with pulmo-
nary tuberculosis from the same population.
MATERIALS AND METHODS
Patients. The patients were recruited to the study as described previously (12,
28). All patients were from a single ethnicity (Vietnamese Kinh), were older than
14 years, had a negative HIV test, and gave written informed consent to enter the
study.
Briefly, patients with tuberculous meningitis were recruited at Pham Ngoc
Thach Hospital for Tuberculosis and Lung Diseases and the Hospital for Trop-
ical Diseases in Ho Chi Minh City, Vietnam, between March 2000 and April
2003. To enter the study, patients had to have clinical evidence of meningitis
(nuchal rigidity and abnormal cerebrospinal fluid [CSF] parameters) with M.
tuberculosis cultured from the CSF.
Patients with pulmonary tuberculosis were recruited between September 2003
and December 2004 at five district tuberculosis control units from Ho Chi Minh
City and the surrounding districts, chosen to represent the geographic distribu-
tion of the patients with tuberculous meningitis. To enter the study, patients had
to have a chest X-ray appearance consistent with active tuberculosis (without
evidence of miliary or extrapulmonary tuberculosis), no clinical evidence of
extrapulmonary disease, and M. tuberculosis cultured from sputum. Patients with
a history of previous tuberculosis treatment were excluded.
The study protocols were approved by the human subject review committees
at the Hospital for Tropical Diseases, Pham Ngoc Thach Hospital for Tubercu-
losis and Lung Disease, and the Health Services of Ho Chi Minh City in Viet-
nam. Ethical approval was also granted by the Oxfordshire Clinical Research
Ethics Committee and the Oxford Tropical Research Ethics Committee.
Clinical phenotype. All clinical data were recorded by physicians without
knowledge of the mycobacterial genotype results. Patients with pulmonary tu-
berculosis were not followed after the start of treatment. The results of chest
radiography before the start of treatment were the only clinical data available
from these patients. The chest radiographs were read by an independent radi-
ologist following predefined criteria (see Table 1) and blind to the patient
laboratory details.
Patients with tuberculous meningitis were followed for 9 months after the start
of treatment. The response to treatment was assessed by clinical examination and
repeated CSF examinations (on days 3, 7, 30, 60, and 270 of treatment) as part
of the routine standard of care. The presenting clinical details and response to
treatment were recorded prospectively in individual clinical record forms. Dis-
ability was assessed for survivors by using the modified Rankin score (31). The
influence of mycobacterial genotype on the response to treatment was not as-
sessed for patients with meningitis caused by bacteria resistant to at least isoni-
azid and rifampin (multidrug resistant), since multidrug resistance is a strong,
independent risk factor for death (30).
M. tuberculosis genotype and drug susceptibility. All M. tuberculosis isolates
were genotyped by large sequence polymorphisms, following the method of
Tsolaki et al. (34). Isolates were first characterized for RD105 and RD239
deletion, since it was anticipated that the majority of isolates would contain one
of these two deletions. RD105-deleted isolates were further subdivided by ex-
amining deletions RD150, RD181, and RD142 (34). For isolates without RD105
or RD239, the pks gene was sequenced to identify the Euro-American lineage,
using primers pksi (GCAGGCGATGCGTCATGGGG) and pksj (TCTTGCCC
ACCGACCCTGGC) to amplify a 520-bp fragment (7). After purification, the
products were sequenced on the CEQ8000 system (Beckman Coulter, Singa-
pore). Multiplex allele specific-PCR was used to screen other isolates for the
pks15/1 7-bp deletion, using outer primers pks1i (3-GCAGGCGATGCGTCA
TGGGG-5) and pks1j (3-TCTTGCCCACCGACCCTGGC-5) (7) and an in-
ternal primer, pks1insR (3-ACGGCTGCGGCTCCCGATGCT-5). Isolates
with the 7-bp deletion produced two bands, of 520 bp and 259 bp, while isolates
without the deletion produce a single band of 520 bp, validated by comparison
with sequencing data for 43 wild-type and 12 isolates with the pks15/1 7-bp
deletion.
M. tuberculosis isolates were tested for susceptibilities to isoniazid, rifampin,
ethambutol, and streptomycin by the proportion method (6). If the number of
colonies growing on drug-containing medium (isoniazid, 0.2 g/liter; rifampin,
40.0 g/liter; ethambutol, 2.0 g/liter; and streptomycin, 4.0 g/liter) was 1%
of that growing on drug-free medium, the isolate was considered to be resistant.
Statistical analysis. The clinical variables of disease caused by the different
mycobacterial lineages were compared by the chi-square test if the data were
categorical and the Kruskal-Wallis or Mann-Whitney U tests if the data were
continuous. Multivariate analysis was performed using forward stepwise binary
logistic regression (with a P value of 0.05 to enter and a P value of 0.055 to
remove) to overcome the hazards of multiple univariate testing and to identify
presenting clinical variables independently associated with mycobacterial lineage
and outcome. Statistical analyses were performed using the SPSS software pro-
gram, version 14.0 (SPSS, Inc.).
RESULTS
Genotypes were determined for mycobacteria from 235
adults with pulmonary tuberculosis and 162 adults with tuber-
culous meningitis. All of the isolates were placed in one of
three lineages defined by Gagneux et al. (10, 11). Those with
TABLE 1. Relationship between M. tuberculosis lineage and chest
X-ray appearances at the start of treatment for 235 adults
with pulmonary tuberculosis
Appearance on
chest X-ray
No. (%) of patients carrying isolate with
lineage identificationa
P value
East Asian/
Beijing Indo-Oceanic Euro-American
Consolidation 51 (51.5) 53 (51.0) 26 (81.3) 0.006
 Unilateral 41 (80.4) 40 (75.5) 22 (84.6)
 Bilateral 10 (19.6) 13 (24.5) 4 (15.4) 0.620
Cavitation 44 (44.4) 41 (39.4) 11 (34.4) 0.556
 Unilateral 41 (93.2) 29 (70.7) 11 (100)
 Bilateral 3 (6.8) 12 (29.3) 0 0.005
Pleural thickening 3 (3.0) 6 (5.8) 1 (3.1) 0.592
Fibrosis 17 (17.2) 15 (14.4) 2 (6.3) 0.312
Intrathoracic lymph
node enlargement
9 (9.1) 14 (13.5) 2 (6.3) 0.413
 Unilateral 9 (100) 12 (85.7) 2 (100)
 Bilateral 0 2 (14.3) 0 0.426
 Hilar 5 (55.6) 6 (42.9) 1 (50.0)
 Mediastinal 4 (44.4) 8 (57.1) 1 (50.0) 0.625
a For the East Asian/Beijing lineage, n  99 isolates; for Indo-Oceanic, n 
104; for Euro-American, n  32.
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the RD105 deletion were defined as the East Asian or W-
Beijing lineage; those with the RD239 deletion were defined as
the Indo-Oceanic lineage; and those with neither of these
deletions but with the 7-bp deletion in pks15/1 were defined as
the Euro-American lineage.
Mycobacterial genotype and radiographic appearance of
pulmonary tuberculosis. Table 1 presents a comparison of the
pretreatment radiographic features of pulmonary tuberculosis
caused by bacteria of the three lineages. The principal finding
was that isolates of the Euro-American lineage were signifi-
cantly more likely than isolates of the other two lineages to be
associated with the radiographic appearances of lung consoli-
dation (P  0.006).
We also examined whether the subdivisions of the East
Asian/Beijing lineage described by Tsolaki et al. (34) were
associated with specific radiological features. Subdivision data
were unavailable from 14 of the 99 East Asian/Beijing isolates.
Of the remainder, 3/85 (3.5%) had no RD181 deletion (group
1), 71/85 (83.5%) had RD181 deleted alone (group 2), and
11/85 (12.9%) had both RD181 and RD150 deletions (group
3). None of the isolates had the RD142 deletion. When the
radiological features of pulmonary tuberculosis were com-
pared across the subdivisions, there was a difference in the
proportion with fibrosis: pulmonary fibrosis was observed in
2/3 (66.7%) of patients in group 1, 14/71 (19.7%) in group 2,
and 0/11 in group 3 (P 0.027). None of the other radiological
features were significantly associated (P  0.05) with the sub-
divisions (data not presented).
Mycobacterial genotype and presentation of tuberculous
meningitis. Table 2 presents a comparison of the pretreatment
clinical features of tuberculous meningitis caused by bacteria
of the three lineages. The durations of illness before presen-
tation to the hospital were significantly different across the
lineages (P  0.003), with patients with disease caused by the
East Asian/Beijing lineage presenting with shorter illnesses
than those with meningitis caused by the other lineages. This
finding is unlikely to be caused by differences in presenting-
disease severity between the groups, since there was a trend
(P  0.059) for patients with disease caused by East Asian/
Beijing bacteria to present with disease more severe than those
caused by other lineages. As with the pulmonary isolates, men-
ingitis caused by the East Asian/Beijing lineage were far more
likely to be resistant to one or more first-line antituberculosis
drugs.
We then examined the features of meningitis caused by the
East Asian/Beijing lineage more closely. Compared with the
Indo-Oceanic and Euro-American lineages, disease caused by
the East Asian/Beijing lineages occurred in significantly
younger adults (median [range] for East Asian/Beijing, 29
years [16 to 78], versus 35 years [15 to 82] for the rest) and with
a significantly shorter duration of illness to treatment (median
[range] for East Asian/Beijing, 14 days [4 to 90 days], versus 17
TABLE 2. Univariate analysis of relationship between M. tuberculosis lineage and clinical features of tuberculous meningitis
at start of treatmenta
Clinical variableb
Value median (range) or no. (%), no. of patients tested for patients carrying
mycobacteria with lineage identification P value
East Asian/Beijing Indo-Oceanic Euro-American
Age (yr) 29 (16–78), 74 35 (15–82), 80 34 (15–77), 8 0.121
Male sex 39 (52.7), 74 35 (43.8), 80 2 (25.0), 8 0.239
Duration of illness (days) 14 (4–90), 74 17 (6–90), 80 23 (10–30), 8 0.003
Temp (°C) 38.5 (37.0–40.6), 74 38.5 (37.0–40.2), 80 37.9 (37.0–39.0), 8 0.157
MRC severity grade
I 14 (18.9) 26 (32.5) 0
II 35 (47.3) 38 (47.5) 4 (50.0) 0.059
III 25 (33.8), 74 16 (20.0), 80 4 (50.0), 8
Glasgow coma score (n/15) 14 (3–15), 74 14 (3–15), 80 12 (9–15), 8 0.144
Cranial nerve palsy 29 (39.2), 74 29 (36.3), 80 6 (75.0), 8 0.102
Hemiplegic 12 (16.2), 74 7 (8.8), 80 4 (50.0), 8 0.050
CSF parameters
Opening pressure (cm H2O) 27 (5–41), 54 25 (7–41), 55 20 (14–40), 5 0.976
Total white cell count (106/ml) 160 (5–1,435), 73 248 (3–1,770), 80 96 (10–290) 0.025
% Neutrophils 28 (0–90) 33 (0–97) 33 (0–90) 0.889
% Lymphocytes 72 (10–100) 67 (3–100) 67 (40–100), 8 0.768
Total protein (mg/dl) 160 (38–820), 73 142 (23–2,500), 79 183 (83–490), 8 0.605
CSF glucose/blood glucose 0.25 (0.05–0.56), 74 0.26 (0.06–0.67) 0.26 (0.11–0.39), 8 0.338
Lactate (mmol/liter) 6.4 (2.7–15.1), 37 7.2 (3.1–16.4), 40 8.3 (7.7–8.9), 2 0.806
IFN-	 (pg/ml) 1,086.6 (24.7–29,576.0), 33 935.0 (76.2–9,126.1), 27 9,498.4 (9,498.4), 1 0.142
TNF-
 (pg/ml) 11.4 (0.1–391.8), 32 11.3 (0–301.6), 27 132.1 (132.1), 1 0.335
IL-10 (pg/ml) 57.7 (4.3–404.1), 32 60.0 (14.6–715.1), 27 75.8 (75.8), 1 0.811
IL-6 (pg/ml) 9,506.2 (668.0–78,060.0), 32 10,341.8 (2,218.2–94,730.0), 27 12,670.2 (12,670.2), 1 0.599
IL-8 (pg/ml) 3,304.8 (627.8–12,440.7), 32 2,484.1 (829.6–18,270.8), 27 2,785.0 (2,785.0), 1 0.967
Drug susceptibility of mycobacteria
Fully sensitive 34 (45.9) 65 (81.3) 6 (75.0)
Resistant to isoniazid and/or streptomycin 36 (48.6) 13 (16.7) 2 (25.0) 0.001
Multidrug resistant 4 (5.4), 74 1 (1.3) 0
a Categorical variables were compared by using the chi-square test, continuous variables by using the Kruskal-Wallis test.
b MRC, Medical Research Council; IFN-	, gamma interferon; TNF-
, tumor necrosis factor alpha; IL-10, -6, and -8, interleukins 10, 6, and 8.
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days [6 to 90 days] in the rest). Binary logistic regression was
used to determine the clinical variables independently associ-
ated with meningitis caused by bacteria from the East Asian/
Beijing lineage. CSF cytokine data were initially excluded due
to large numbers of missing variables limiting the size of the
model. A shorter duration of illness (odds ratio, 0.973; 95%
confidence interval [CI], 0.948 to 0.999; P  0.039) and fewer
CSF leukocytes (odds ratio, 0.999; 95% CI, 0.997 to 1.000; P 
0.026) were independently associated with the East Asian/
Beijing lineage. When the cytokine data (gamma interferon,
tumor necrosis factor alpha, interleukin-10, and interleukin-8)
were entered into the model, only young age (odds ratio, 0.947;
95% CI, 0.906 to 0.990; P  0.017) and fewer CSF leukocytes
(odds ratio, 0.997; 95% CI, 0.995 to 0.999; P  0.023) were
independently associated with the East Asian/Beijing lineage,
but this reduced the size of the model from 157 to 60 patients.
Data concerning the East Asian/Beijing subdivisions were
available for all 74 isolates in the tuberculous meningitis group:
14/74 (18.9%) had no RD181 deletion (group 1), 35/74
(47.3%) had the RD181 deletion alone (group 2), and 25/74
(33.8%) had both the RD181 and RD150 deletions (group 3).
No significant associations (P  0.05) were found between the
groups and the presenting clinical features of tuberculous men-
ingitis (data not presented).
Mycobacterial genotype and outcome of tuberculous men-
ingitis. Figure 1a to c shows the influence of mycobacterial
genotype on the change in the CSF parameters of total leuko-
cyte count, CSF glucose/blood glucose ratio, and CSF gamma
interferon during treatment. No significant differences in re-
sponse were observed between the bacterial lineages.
By 9 months of treatment for tuberculous meningitis, death
had occurred in 14/70 (20.0%) of patients infected with the
East Asian/Beijing lineage, 16/78 (20.5%) of patients infected
with the Indo-Oceanic lineage, and 0/8 of patients infected
with the Euro-American lineage (P 0.365). The combination
of death or severe disability by 9 months of treatment occurred
in 28/74 (34.3%) of patients infected with the East Asian/
Beijing lineage, 20/78 (25.6%) of patients infected with the
Indo-Oceanic lineage, and 2/8 (25.0%) of patients infected
with the Euro-American lineage (P  0.495). A higher pro-
portion of patients with disease caused by the East Asian/
Beijing lineage were dead or severely disabled (34.3% versus
25.6%) by 9 months than was the case for those with disease
caused by all other lineages, but this difference was not signif-
icant (P  0.236).
Logistic regression was used to model the presenting clinical
variables independently associated with death or severe dis-
ability (using disease caused/not caused by the East Asian/
Beijing lineage as a covariable). We found that older age (odds
ratio, 1.034; 95% CI, 1.010 to 1.060; P  0.006), fewer CSF
leukocytes (odds ratio, 0.998; 95% CI, 0.997 to 0.999; P 
0.026), and the presence of hemiplegia (odds ratio, 5.244; 95%
CI, 1.824 to 15.082; P  0.002) but not strain lineage were
associated with death or severe disability.
Mycobacterial genotype and drug resistance. There was a
strong association between isolates of the East Asian/Beijing
lineage and drug resistance for both pulmonary and meningeal
disease. Fifty-three of ninety-nine (53.4%) of East Asian/Bei-
jing isolates causing pulmonary tuberculosis were resistant to
one or more first-line drugs, compared to 21/104 isolates
FIG. 1. The influence of mycobacterial lineage on the response of
CSF parameters to treatment for patients with tuberculous meningitis
(error bars represent 95% confidence intervals). (a) Mycobacterial
lineage and mean CSF total leukocyte count during treatment. (b)
Mycobacterial lineage and mean CSF/plasma glucose ratios during
treatment. (c) Mycobacterial lineage and log10 mean CSF gamma
interferon concentration during treatment.
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(20.2%) of the Indo-Oceanic lineage and 11/32 (34.4%) iso-
lates of the Euro-American lineage (P  0.001). The findings
were similar for tuberculous meningitis (Table 2).
DISCUSSION
It is uncertain whether or not the genetic diversity of M.
tuberculosis has any important clinical consequences. There is
a substantial body of evidence from cellular and animal infec-
tion models that suggests different strains of M. tuberculosis
invoke different innate and adaptive immune responses (11,
16) but very little data on how these differences might influ-
ence clinical presentation and outcome for tuberculosis in hu-
mans. This is partly because such studies require large numbers
of well-characterized patients. Here we report the results of a
substantial investigation into the relationship between myco-
bacterial genotype and the clinical phenotype of pulmonary
and meningeal tuberculosis.
We found that the clinical presentation of both forms of
tuberculosis is influenced by the mycobacterial genotype. The
radiological appearance of pulmonary consolidation was sig-
nificantly more common in disease caused by the Euro-Amer-
ican lineage than in that caused by other lineages. Consolida-
tion is caused by air spaces filled with inflammatory cells and
exudate and therefore may reflect a differential inflammatory
response between the lineages. However, the nature and extent
of pulmonary disease may also be influenced by other factors,
such as the duration of illness prior to diagnosis. We were not
able to adjust the analysis for these covariables, and therefore,
our conclusions concerning the influence of the mycobacterial
genotype on pulmonary tuberculosis pathogenesis remain specu-
lative.
In contrast, we were able to characterize the presenting
features and response to treatment of tuberculous meningitis
in greater detail. The principle findings arising from the mul-
tivariate analysis were that tuberculous meningitis caused by
the East Asian/Beijing lineage was independently associated
with a shorter duration of illness and lower numbers of leuko-
cytes in the CSF at presentation. This suggests the mycobac-
terial genotype influences disease progression and the devel-
opment of the intracerebral inflammatory response.
Tuberculous meningitis develops following the release of
small numbers of bacteria into the subarachnoid space from
small subpial or subependymal granuloma (Rich foci) formed
during an earlier bacteremia (26). Symptoms develop slowly,
dependent upon the numbers of initial bacteria, their speed of
replication, and the immune response they invoke. The out-
come is intimately associated with treatment before the onset
of coma (13), but the relationship between coma severity, the
duration of symptoms, and the intracerebral inflammatory re-
sponse is poorly defined. Previous studies have failed to show
a linear relationship between the duration of illness and coma
and have suggested other unknown factors may influence this
relationship (29, 32). Mycobacterial lineage appears to be one
of those factors: patients with meningitis caused by the East
Asian/Beijing lineage have more rapidly progressive disease
with a shorter duration of symptoms independent of disease
severity at presentation.
In addition, the independent association between the East
Asian/Beijing lineage and low CSF leukocyte numbers sup-
ports the proposal that the mycobacterial lineage influences
the intracerebral inflammatory response. CSF cytokine con-
centrations were measured for a small proportion of the pa-
tients, but this failed to show any significant relationship with
the mycobacterial lineage. However, previous studies have
shown CSF cytokine concentrations correlate poorly with
coma and outcome from tuberculous meningitis (27). Instead,
this and previous studies have shown that a low CSF leukocyte
count is an independent predictor of death (32). We were not
able to show that meningitis caused by the East Asian/Beijing
lineage was an independent risk factor for a poor outcome—
perhaps because the study was not sufficiently powered to
demonstrate such an effect—but the bilateral relationship be-
tween a low CSF leukocyte count, the East Asian/Beijing lin-
eage, and a poor outcome suggests the bacteria differentially
influence a critical part of disease pathogenesis.
There are additional ways in which the mycobacterial geno-
type may influence the outcome for tuberculosis. Although we
did not find a clear relationship between mycobacterial lineage
and outcome from tuberculous meningitis when those with
multidrug-resistant disease were excluded from the analysis,
there was a clear association between the East Asian/Beijing
lineage and resistance to one or more first-line drugs (includ-
ing multidrug resistance). The same association was found for
the pulmonary isolates. Multidrug resistance is a strong inde-
pendent risk factor for a poor outcome for all forms of tuber-
culosis (21) and, when strongly linked to mycobacterial geno-
type, provides a clinically important influence of the bacterial
genotype on the outcome. We recently reported a strong as-
sociation between the Beijing genotype and drug resistance for
HIV-infected Vietnamese adults with tuberculous meningitis
(5). This study suggests the relationship holds for HIV-unin-
fected adults with pulmonary disease, and similar findings have
been reported from Russia (9) and Kazakhstan (15).
In summary, we have found that the genotype of M. tuber-
culosis has important clinical consequences since it influences
the presenting features of pulmonary and meningeal tubercu-
losis. In particular, meningitis caused by the East Asian/Beijing
lineage presented with a shorter duration of symptoms inde-
pendent of disease severity and was associated with fewer CSF
leukocytes, which in turn was an independent risk factor for
death or severe disability. These findings suggest the East
Asian/Beijing lineage alters disease presentation by influencing
the intracerebral inflammatory response. In addition, the East
Asian/Beijing lineage was strongly associated with drug-resis-
tant pulmonary and meningeal disease, providing an additional
mechanism by which the bacterial genotype influences the clin-
ical outcome.
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